Price loading...

Springer Varicella-zoster Virus: 342 (Current Topics in Microbiology and Immunology, 342)

Price data last checked 91 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Varicella-zostervirus(VZV)isamedicallyimportanthumanherpesvirus,belo- ingtothesubfamilyAlphaherpesviridae. Thecapacitytopersistinsensoryneurons isade?ningcharacteristicoftheAlphaherpesviridaesubgroupwhichalsoincludes herpessimplexvirus1and2;likeVZV,simianvaricellavirus(SVV),pseudorabies virus-1(PRV-1),andequineherpesvirus-1(EHV-1)belongtotheVaricellovirus genus. ThebasicelementsoftheinfectiouscycleofVZVinthehumanhostarethat infectionofthena?vehostresultsinvaricella,commonlyknownaschickenpox, latencyisestablishedinsensoryganglia,andreactivationcauseszosteror"sh- gles. "Therelationshipbetweenthecausative agentofvaricellaandzoster was demonstratedmorethan100yearsagowhenchildreninoculatedwithmaterialfrom zosterlesionswereshowntodevelopvaricella. Thelocalizeddistributionofthe zosterrashwasalsorecognizedasdemarcatingthedematomeinnervatedbyaxons fromneuronsineachofthesensoryganglia. Earlyelectronmicroscopystudies showedthatvirusparticleswerepresentinhighconcentrationsinthevesicular ?uidfrombothvaricellaandzosterlesions,andVZVwasamongthe?rstviruses propagatedinvitrobyJohnEndersandThomasWeller. Theintroductionofim- nosuppressivetherapiesformalignancyledtoobservationssuggestingtheneed forcell-mediatedimmunityinthehostresponsetovaricellaanditsroleinma- tainingVZVlatency. Fortunately,earlystudiesofthemolecularvirologyofVZV revealedthatitwasinhibitedbyinterferencewiththethymidinekinasegene,and thelife-threateningandoftenfatalVZVinfectionsexperiencedbythesepatients becametreatablewithantiviraldrugs. Subsequently,thecapacitytogrowVZVin tissueculturewasexploitedtocreatealiveattenuatedVZVvaccinebyMichiaki Tashihaki. Whilenowtakenforgranted,theseearlyinsightsaboutVZVandits characteristicsasahumanpathogenaswellasthedevelopmentofeffectivean- viral drugs and vaccines occurred over many decades. Importantly, these early observationssetthestagefortheremarkableprogressthathasbeenmadeinour understandingofthemolecularbiologyofVZV,thesubtletiesofitstropismfor differentiatedhumancells,includinglymphocytesaswellasskinandneurons,and themechanismsbywhichthevirusachievesanequilibriumwiththehostsothatit persistsnotjustintheindividualbutinthehumanpopulation. v vi Preface Thepurposeofthisvolumeistoreviewkeyareasofprogressinthe?eldofVZV research,aswellasworkontherelatedSVV,writtenbythosewhohavecontributed manyofthenew? ndingsthathaveenrichedourknowledgeoftheuniquech- acteristicsofthisubiquitoushumanpathogen. AlthoughtheVZVgenomeisthe smallestamongthehumanherpesviruses,therapidlyacceleratingpaceofdiscovery about VZV and VZV-host interactions re?ected in these reviews promises to continueasnewtoolsareavailableandnewhypothesesaregeneratedtoexplain howVZVhascreatedandmaintaineditsnicheinthehuman"virome"Therelationshipbetweenthecausative agentofvaricellaandzoster was demonstratedmorethan100yearsagowhenchildreninoculatedwithmaterialfrom zosterlesionswereshowntodevelopvaricella. Thelocalizeddistributionofthe zosterrashwasalsorecognizedasdemarcatingthedematomeinnervatedbyaxons fromneuronsineachofthesensoryganglia. Earlyelectronmicroscopystudies showedthatvirusparticleswerepresentinhighconcentrationsinthevesicular ?uidfrombothvaricellaandzosterlesions,andVZVwasamongthe?rstviruses propagatedinvitrobyJohnEndersandThomasWeller. Theintroductionofim- nosuppressivetherapiesformalignancyledtoobservationssuggestingtheneed forcell-mediatedimmunityinthehostresponsetovaricellaanditsroleinma- tainingVZVlatency. Fortunately,earlystudiesofthemolecularvirologyofVZV revealedthatitwasinhibitedbyinterferencewiththethymidinekinasegene,and thelife-threateningandoftenfatalVZVinfectionsexperiencedbythesepatients becametreatablewithantiviraldrugs. Subsequently,thecapacitytogrowVZVin tissueculturewasexploitedtocreatealiveattenuatedVZVvaccinebyMichiaki Tashihaki. Whilenowtakenforgranted,theseearlyinsightsaboutVZVandits characteristicsasahumanpathogenaswellasthedevelopmentofeffectivean- viral drugs and vaccines occurred over many decades. Importantly, these early observationssetthestagefortheremarkableprogressthathasbeenmadeinour understandingofthemolecularbiologyofVZV,thesubtletiesofitstropismfor differentiatedhumancells,includinglymphocytesaswellasskinandneurons,and themechanismsbywhichthevirusachievesanequilibriumwiththehostsothatit persistsnotjustintheindividualbutinthehumanpopulation. v vi Preface Thepurposeofthisvolumeistoreviewkeyareasofprogressinthe?eldofVZV research,aswellasworkontherelatedSVV,writtenbythosewhohavecontributed manyofthenew?ndingsthathaveenrichedourknowledgeoftheuniquech- acteristicsofthisubiquitoushumanpathogen. AlthoughtheVZVgenomeisthe smallestamongthehumanherpesviruses,therapidlyacceleratingpaceofdiscovery about VZV and VZV-host interactions re?ected in these reviews promises to continueasnewtoolsareavailableandnewhypothesesaregeneratedtoexplain howVZVhascreatedandmaintaineditsnicheinthehuman"virome"sos- cessfully. Further improvements in the clinical management of VZV infection shouldemergeinparallelwithbetterinsightsintoVZVmolecularvirologyand pat

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Varicella-zoster Virus: 342 (Current Topics in Microbiology and Immunology, 342)
96% match

Varicella-zoster Virus: 342 (Current Topics in Microbiology and Immunology, 342)

Springer

£177.97 11 Jan 2026
Current Topics in Microbiology and Immunology: 97
95% match

Current Topics in Microbiology and Immunology: 97

Springer

£89.99 07 Mar 2026
Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention
94% match

Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention

Adis

£81.44 11 Mar 2026
Advances in Virus Research (Volume 62)
94% match

Advances in Virus Research (Volume 62)

Academic Press

£83.80 05 Feb 2026
Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention
94% match

Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention

Adis

£73.75 24 Jan 2026
Chikungunya Virus: 435 (Current Topics in Microbiology and Immunology, 435)
93% match

Chikungunya Virus: 435 (Current Topics in Microbiology and Immunology, 435)

Springer

£100.00 09 Mar 2026
Innate Antiviral Immunity: Methods and Protocols: 1656 (Methods in Molecular Biology, 1656)
93% match

Innate Antiviral Immunity: Methods and Protocols: 1656 (Methods in Molecular Biology, 1656)

Humana

£99.54 05 Feb 2026
Epstein-Barr Virus Protocols: 174 (Methods in Molecular Biology, 174)
93% match

Epstein-Barr Virus Protocols: 174 (Methods in Molecular Biology, 174)

Humana

£108.78 20 Apr 2026
Marburg- and Ebolaviruses: From Ecosystems to Molecules: 411 (Current Topics in Microbiology and Immunology, 411)
93% match

Marburg- and Ebolaviruses: From Ecosystems to Molecules: 411 (Current Topics in Microbiology and Immunology, 411)

Springer

£104.23 12 Apr 2026
Viruses: Molecular Biology, Host Interactions, and Applications to Biotechnology
93% match

Viruses: Molecular Biology, Host Interactions, and Applications to Biotechnology

Academic Press

£67.99 24 Feb 2026
Viral Hemorrhagic Fevers
93% match

Viral Hemorrhagic Fevers

CRC Press

£60.99 07 Mar 2026
Springer - The Molecular Biology of Poliovirus Monograph
93% match

Springer - The Molecular Biology of Poliovirus Monograph

Springer

£136.40 18 Apr 2026
Henipavirus: Ecology, Molecular Virology, and Pathogenesis: 359 (Current Topics in Microbiology and Immunology, 359)
93% match

Henipavirus: Ecology, Molecular Virology, and Pathogenesis: 359 (Current Topics in Microbiology and Immunology, 359)

Springer

£127.83 11 Feb 2026
Advances in Virus Research: Volume 89
93% match

Advances in Virus Research: Volume 89

Academic Press

£96.25 09 Mar 2026
Human Viruses: Diseases, Treatments and Vaccines: The New Insights
93% match

Human Viruses: Diseases, Treatments and Vaccines: The New Insights

Springer

£93.49 09 Mar 2026
Molecular Biology of Plant Viruses
93% match

Molecular Biology of Plant Viruses

Springer

£117.10 09 Mar 2026
Human Virology
93% match

Human Virology

Oxford University Press

£55.99 12 Jan 2026
Medical Virology 8
93% match

Medical Virology 8

Springer

£109.90 01 Feb 2026
Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)
93% match

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Springer

£149.64 02 Apr 2026
Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)
93% match

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Springer

£152.38 08 Mar 2026
Cytomegaloviruses: Molecular Biology and Immunology
93% match

Cytomegaloviruses: Molecular Biology and Immunology

Caister Academic Press Limited

£249.97 13 Dec 2025
Advances in Virus Research: Volume 81
93% match

Advances in Virus Research: Volume 81

Academic Press

£104.79 09 Mar 2026
Animal-Origin Viral Zoonoses (Livestock Diseases and Management)
93% match

Animal-Origin Viral Zoonoses (Livestock Diseases and Management)

Springer

£73.97 09 Mar 2026
Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)
93% match

Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)

Springer

£73.91 20 Feb 2026